论文部分内容阅读
目的:探讨胸腺肽α1辅助治疗老年慢性阻塞性肺疾病(COPD)患者的临床效果。方法:选取我院接收的140例老年COPD患者作为本次的研究对象,以随机分配原则将所有患者分为两组,即观察组和对照组,各70例,对照组采用常规治疗,观察组则在此基础上加行胸腺肽α1辅助治疗,比较两组患者的临床疗效。结果:两组患者治疗总有效率相比较有统计学意义(P<0.05)。结论:在常规治疗的基础上给予老年COPD患者胸腺肽α1辅助治疗可有效提高治疗效果,有较高的应用价值,应得到推广应用。
Objective: To investigate the clinical effect of thymosin α1 in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD). Methods: A total of 140 elderly patients with COPD received in our hospital were selected as the study subjects. All patients were divided into two groups according to the principle of random assignment: observation group and control group, 70 cases in each group. The control group was treated by conventional therapy and observation group Then on this basis plus thymosin α1 adjuvant therapy, the clinical efficacy of two groups were compared. Results: The total effective rate of two groups was statistically significant (P <0.05). Conclusion: The adjuvant thymosin α1 given to elderly COPD patients on the basis of routine treatment can effectively improve the therapeutic effect, which has high value of application and should be popularized and applied.